Medical and Pharmaceutical Industry - Market Research Report

The global   in vitro diagnostics (IVD) quality control market   size was estimated at USD 1.28 billion in 2023 and is projected to reach USD 1.59 billion by 2030, expanding at a CAGR of 3.2% from 2024 to 2030. The rise in the number of certified clinical laboratories offering reliable IVD-based diagnostic services has strengthened patient confidence, which continues to fuel market demand. Key Market Trends & Insights North America dominated the in vitro diagnostics quality control market with a 47.1% share in 2023. The U.S. accounted for a significant portion of the global market in 2023. By product, the controls segment led the market with a 48.3% share in 2023. By type, the quality controls segment captured the largest revenue share in 2023. By application, the immunochemistry segment held the largest revenue share in 2023. Market Size & Forecast 2023 Market Size: USD 1.28 Billion 2030 Projected Market Size: USD 1.59 Billion CAGR (2024–2030): 3.2% North America: Lar...

The global   flow cytometry market   was valued at approximately USD 4,684.2 million in 2024, and is expected to grow to around USD 7,013.1 million by 2030, expanding at a compound annual growth rate (CAGR) of 8.41% from 2025 to 2030. The main drivers behind this growth include rising incidences of cancer, immunodeficiency disorders, and infectious diseases, which are fueling demand for flow cytometry technologies. Key Market Trends & Insights North America dominated the flow cytometry market with the largest revenue share of 41.35% in 2024. The flow cytometry market in the U.S. is expected to experience at a robust CAGR between 2024 and 2030 By product, the instrument segment led the market with the largest revenue share of 35.30% in 2024. Based on technology, the cell-based segment led the market with the largest revenue share of 76.16% in 2024. Based on application, the clinical segment led the market with the largest revenue share of 45.34% in 2024. Based on end use, t...

The global   aesthetic medicine market   size was estimated at USD 89.64 billion in 2024 and is projected to reach USD 239.98 billion by 2033, expanding at a CAGR of 11.73% from 2025 to 2033. This strong growth is driven by the rising adoption of minimally invasive and noninvasive cosmetic procedures, along with a growing population seeking solutions for age-related concerns. Key Market Trends & Insights North America accounted for the largest revenue share at 33.74% in 2024. The aesthetic medicine industry in Canada is expected to register the fastest CAGR from 2025 to 2033. By procedure type, invasive procedures held the largest market share in 2024. By end use, clinics and aesthetic centers dominated the market with a 48.09% share in 2024. Market Size & Forecast 2024 Market Size: USD 89.64 Billion 2033 Projected Market Size: USD 239.98 Billion CAGR (2025–2033): 11.73% Largest Regional Market (2024): North America According to the ISAPS report, 17.42 million surgical...

The global   active pharmaceutical ingredients (API) market   size was estimated at USD 255.00 billion in 2024 and is projected to reach USD 359.45 billion by 2030, expanding at a CAGR of 5.8% from 2025 to 2030. Market growth is largely driven by rising global demand for pharmaceutical drugs, particularly in emerging economies, alongside the increasing burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Advancements in biologics, biosimilars, and innovative drug formulations are further fueling the demand for specialized APIs. Additionally, the continual shift toward generic medicines and the rapid expansion of contract manufacturing organizations (CMOs) are significantly contributing to API production and distribution efficiency. Key Market Trends & Insights North America dominated the API market with a 38.04% revenue share in 2024. Asia Pacific is expected to register the fastest CAGR during the forecast period. Based on type of synthesis, ...

The global   surgical robotic services market   was valued at USD 1.53 billion in 2023 and is forecasted to reach USD 3.73 billion by 2030, expanding at a CAGR of 13.9% from 2024 to 2030. Market growth is primarily driven by the rising adoption of robotic technologies in surgical procedures, the increasing demand for specialized surgical expertise, and the growing need for remote monitoring and telesurgery solutions. Additionally, the shift toward cost-effective service models is further strengthening market expansion. Key Market Trends & Insights North America held the dominant position in the global surgical robotic services market, accounting for 49.85% of total revenue in 2023. The U.S. remained the leading contributor within the region. In terms of application, neurology is projected to grow the fastest, registering a CAGR of 22.5% over the forecast period. By end-use, inpatient facilities led the market with a 53.21% revenue share in 2023, due to increased adoption o...

The global   lateral flow assays market   size was estimated at USD 9.85 billion in 2024 and is projected to reach USD 17.44 billion by 2033, expanding at a CAGR of 6.98% from 2025 to 2033. This growth is driven by the increasing incidence of infectious diseases, continuous technological innovation in assay development, and the rising adoption of rapid diagnostic tools in both home-care and point-of-care settings. Key Market Trends & Insights North America dominated the global lateral flow assays market, accounting for 35.44% of total revenue in 2024. The U.S. retained the largest share within the North American region in 2024. By product, kits and reagents led the market with a 66.50% revenue share in 2024. By application, clinical testing held the largest share at 74.33% in 2024. By technique, the sandwich assays segment accounted for 38.75% revenue share in 2024. By end use, hospitals and clinics were the leading segment, representing 34.90% of the market in 2024. Marke...

The global   Keytruda market   size was valued at USD 29.49 billion in 2024 and is projected to decline to USD 26.63 billion by 2030, registering a negative CAGR of –3.23% from 2025 to 2030. This downturn is primarily linked to the drug’s upcoming patent expiration, which is expected to invite strong biosimilar competition and drive downward pricing pressure. Key Market Trends & Insights North America leads the global Keytruda market with a 38.0% share in 2024. The U.S. remains the dominant market within North America. Lung cancer is the leading application segment, accounting for 27.4% of the global share in 2024. By payer type, commercial/private insurance holds the majority share of 91.0% in 2024. Hospital pharmacies form the largest distribution channel with 51.8% share in 2024. Market Size & Forecast 2024 Market Size: USD 29.49 Billion 2030 Forecast Size: USD 26.63 Billion CAGR (2025–2030): –3.23% Largest Market in 2024: North America Despite the projected decline...

The global   interventional oncology market   size was valued at USD 2.7 billion in 2024 and is projected to reach USD 4.38 billion by 2030, expanding at a CAGR of 8.55% from 2025 to 2030. This growth is driven by the increasing prevalence of cancer, continuous technological advancements in minimally invasive procedures, the expanding geriatric population, rising emphasis on early cancer detection, and growing public as well as private investments supporting interventional oncology technologies. Key Market Trends & Insights North America dominated the global interventional oncology market, accounting for 41.87% revenue share in 2024. The U.S. market is expected to witness substantial growth throughout the forecast period. By technique, ablation therapies led the market with a 37.1% revenue share in 2024. By procedures, vascular interventions captured the largest share at 38.2% in 2024. By applications, liver cancer remained the leading segment with a 28.0% share in 2024. M...

The global   omega-3 market   was valued at USD 2.62 billion in 2023 and is expected to grow to USD 4.45 billion by 2030, representing a compound annual growth rate (CAGR) of 7.9 % over the 2024-2030 period. The expansion is driven by increased incorporation of omega-3 ingredients into the human diet to support heart and brain health. Key Market Trends & Insights In 2023, the North America region held the largest share of the market, with more than 37.1 % of revenue. Within the type segmentation, docosahexaenoic acid (DHA) led with a revenue share exceeding 56 % for the year. In terms of source, marine-derived omega-3s accounted for the bulk of revenue, with an 83.5 % share in 2023. On the application side, supplements and functional foods dominated the demand side and held over 51 % of the revenue share in 2023. The growing health-awareness of consumers and demand for dietary support to manage cardiovascular and neurological health have reinforced market growth. Moreover,...

The global   neurological biomarkers market   was estimated at USD 9.1 billion in 2024 and is projected to grow to USD 18.75 billion by 2030, representing a compound annual growth rate (CAGR) of 12.9% between 2025 and 2030. Major driving factors include rising prevalence of neurological diseases and growing awareness among physicians and patients alike. Key Market Trends & Insights In 2024, North America held the largest regional share at approximately 41.47% of the market, largely due to strong research funding, growing neurodegenerative disease prevalence, and advanced technological capabilities.  Among applications, Alzheimer’s disease led with a 34.80% share in 2024, reflecting both high disease burden and increased diagnostic activity in that area.  By biomarker type, proteomic biomarkers accounted for the largest segment with 30.62% in 2024, as advances in mass spectrometry and bioinformatics make protein-based diagnostics more viable.  In the end-use ...

The global   wound care market   was estimated at USD 23.15 billion in 2024 and is projected to reach USD 29.57 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.19% during the 2025-2030 period. The rising prevalence of surgical interventions and chronic conditions worldwide is driving demand for wound care products. Key Market Trends & Insights In 2024, North America accounted for the largest share of the market, capturing more than 45.47% of global revenue. The U.S. is expected to remain the dominant regional market during the forecast period. From a product perspective, the advanced wound dressing segment led in 2024 with over 34.96% of the market share. In terms of application, chronic wounds held the largest share at 59.84% in 2024. For end-use, the hospital segment was the largest in 2024 with 36.30% share. Market Size & Forecast The wound care market stood at USD 23.15 billion in 2024 and is expected to grow to USD 29.57 billion by 2030, repr...

The global   wearable technology market   was valued at USD 84.2 billion in 2024 and is expected to reach USD 186.14 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.6% between 2025 and 2030. The increasing prevalence of obesity and chronic illnesses is driving adoption of wearable devices such as body monitors and activity trackers. Key Market Trends & Insights In 2024 the North American wearable technology market captured the largest revenue share, accounting for over 34% of the global total. The United States is poised to record strong growth from 2025 through 2030. From a product perspective, wrist-wear led with over 58% of revenue share in 2024, while in terms of application the consumer electronics segment dominated in 2024. Market Size & Forecast 2024 market size: USD 84.2 billion 2030 projected market size: USD 186.14 billion CAGR (2025-2030): 13.6% By region, North America held the largest share in 2024. The forecast period is characteriz...

The global   single-use bioprocessing market   was estimated at USD 31.71 billion in 2024 and is projected to reach USD 74.09 billion by 2030, representing a compound annual growth rate (CAGR) of 15.44 % from 2025 to 2030. Adoption of single-use bioprocessing systems is being driven by the growing demand for biopharmaceuticals, including monoclonal antibodies, vaccines and recombinant proteins, along with rising investment in biologics development. Key Market Trends & Insights In 2024, the North American region accounted for the largest share of the market, with over 34.96 %. In the U.S., the strong presence of biopharmaceutical manufacturers supports the demand for single‐use technologies. By product category, the simple & peripheral elements segment held the largest share at 48.82 % in 2024, reflecting widespread use of tubing, filters, connectors and transfer systems. In terms of workflow, the upstream bioprocessing segment dominated, capturing approximately 58.23 %...

The global   pharmaceutical sterility testing market   was estimated at USD 1.75 billion in 2024 and is projected to rise to USD 4.64 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.58% between 2025 and 2033. Growth is being driven by increasing government investments, heightened R&D activity, a growing number of drug launches and a stronger focus on product quality and sterility protocols globally. Key Market Trends & Insights In 2024, the North American region held the largest share of the market at 52.88%. From a service model perspective, the outsourcing segment accounted for the largest revenue share at 58.50% in 2024. In terms of test type, bioburden testing led in 2024. Among end-use segments, medical device companies held the largest share in 2024. The development of rigorous sterility testing protocols is being reinforced by stringent regulations and quality control standards, particularly in developing economies such as India and China,...